Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

India says no to UK data exclusivity demand to protect generic drug firms

Bharat Biotech, GSK, PATH enter into product transfer agreement for malaria vaccine

Ruchika Sharma28 Jan 2021 4:52 PM IST

New Delhi: GSK, PATH, and Bharat Biotech (BBIL) have recently announced the signing of a product transfer agreement for the malaria vaccine,...

Reliance strikes Rs 109 crore deal with Breath of Health for distribution of Covid-19 breath test kit

Ruchika Sharma28 Jan 2021 2:41 PM IST

BOH is said to have developed a breath test system that identifies Covid-19 at a success rate of over 95 percent.

Glenmark gets USFDA nod for amphetamine sulfate tablets to treat ADHD

Ruchika Sharma28 Jan 2021 12:59 PM IST

Mumbai: Pharma major, Glenmark Pharmaceuticals Limited, today announced that the company has received final approval by the United States Food...

Dr Reddys, GRA terminate Avigan Trial Study for COVID-19 in Kuwait

Ruchika Sharma28 Jan 2021 12:00 PM IST

Hyderabad: Dr. Reddy's Laboratories Ltd. and Global Response Aid FZCO (GRA) have recently announced the termination of Avigan Trial Study conducted...

Unichem Labs bags USFDA nod for Zonisamide Capsules

Ruchika Sharma28 Jan 2021 11:14 AM IST

Mumbai: Drug maker, Unichem Laboratories Limited, has recently announced that the company has received Abbreviated New Drug Application...

Sanofi to help BioNTech in manufacturing, supplying COVID-19 vaccine

Ruchika Sharma28 Jan 2021 9:15 AM IST

Paris: Sanofi and BioNTech have entered into an agreement under which Sanofi will support manufacturing and supply of BioNTech's COVID-19 vaccine...

Moderna gets recommendations from WHO experts for COVID-19 vaccine usage

Ruchika Sharma27 Jan 2021 1:22 PM IST

Geneva: The World Health Organization (WHO) issued recommendations on Tuesday on the use of the Moderna COVID-19 vaccine and said it was working with...

Novartis intrathecal onasemnogene abeparvovec Phase III study

Novartis Committed to Sandoz generic business: CEO Vas Narasimhan

Ruchika Sharma27 Jan 2021 12:37 PM IST

Zurich: Novartis Chief Executive Vas Narasimhan on Tuesday renewed his commitment to his Sandoz generic unit where sales growth in 2020 stagnated due...

Pfizer to continue seeking Covid-19 vaccine approval in India, if Govt makes purchase commitment: Report

Ruchika Sharma27 Jan 2021 12:28 PM IST

New Delhi: Pfizer Inc will pursue its request for India to approve its COVID-19 vaccine if the government commits to buying shots, the US...

European Union cautions pharma giants of strict export rules amid COVID-19 vaccine delays

Ruchika Sharma27 Jan 2021 11:00 AM IST

Brussels: The European Union on Tuesday warned pharmaceutical giants that have developed coronavirus vaccines with EU aid that it must get its shots...

Takeda India named Top Employer in 2021

Ruchika Sharma26 Jan 2021 11:30 AM IST

New Delhi: Takeda India has recently announced that the company has been named a Top Employer in 2021 by Top Employers Institute. This is also...

Zydus Cadila Desidustat shows efficacy, safety in treating Hypoxia in COVID-19 patients

Ruchika Sharma26 Jan 2021 11:00 AM IST

Ahmedabad: Drug major, Zydus Cadila, has recently announced that the company has received positive results from Phase 2(b) studies of Desidustat...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok